Boxthorn (Lycium barbarum L. and Lycium chinense Mill.): A Comprehensive Reference
1. Identity: Botanical Classification, Common Names, and Natural Source
Boxthorn is the common English name applied to plants of the genus Lycium, a large group of flowering shrubs in the nightshade family. Lycium is a genus of flowering plants in the family Solanaceae, with a disjunct distribution around the globe and species occurring on most continents in temperate and subtropical regions. Common English names for plants of this genus include box-thorn, wolfberry, and desert-thorn.
In the context of dietary supplementation and herbal medicine, "boxthorn" most specifically refers to two closely related species: Lycium barbarum L. (Chinese wolfberry, barbary matrimony vine) and Lycium chinense Mill. (Chinese boxthorn, Chinese teaplant). Lycium barbarum is a shrub native to China, with a present-day range across Asia and southeast Europe; it is one of two species of boxthorn in the family Solanaceae from which the goji berry or wolfberry is harvested, the other being Lycium chinense. L. barbarum is also known by several traditional vernacular names, including boxthorn, Chinese wolfberry, and matrimony vine, especially when referring to L. barbarum or L. chinense.
Lycium barbarum belongs to the family Solanaceae. The berry is fusiform or oblong shaped, with a length ranging from 6–20 mm and diameter 3–10 mm. The orange or dark red berry has a small stylar scar protruding from the top, and skin having a shrunken appearance. The pulp is fleshy and soft with a bitter and sweet taste.
Common names of the plant in English include Chinese wolfberry, barbary matrimony vine, red medlar, or matrimony vine. In the United Kingdom it is also known as Duke of Argyll's tea tree after Archibald Campbell, 3rd Duke of Argyll, who introduced it to the country in the 1730s.
The plant is known as kuko in Japan and gugija in Korea. In traditional Chinese medicine, the fruit is known as Fructus Lycii (Latin) or Gou Qi Zi / gouqi (Chinese). The fruit is known in Traditional Chinese Medicine references as Fructus Lycii, which is Latin for "Lycium fruit."
The generic name Lycium is derived from the Greek word lykion (λυκιον), which was applied by Pliny the Elder (23–79 AD) and Pedanius Dioscorides (ca. 40–90 AD) to a plant known as dyer's buckthorn. It was probably a Rhamnus species and was named for Lycia (Λυκία), the ancient southern Anatolian region in which it grew.
Pharmacopoeial Recognition
The fruit and/or root bark of L. barbarum and/or L. chinense are the most frequently used materials mentioned in pharmacopoeias. The European Pharmacopoeia includes only the dried fruit of L. barbarum. Lycium fruits (Lycii Fructus) and Lycium root bark (Lycii Radices Cortex) are used in several regions officially; however, the quality criteria differ. Lycium chinense is accepted by the pharmacopoeias of Japan, Korea, and Taiwan, but not included in the pharmacopoeias of China, Europe, UK, and Vietnam.
Cultivation and Commercial Production
The shrub is an important commercial crop in northern China, especially in the Ningxia Hui Autonomous Region. China is the largest producer of goji berries worldwide, accounting for approximately 95,000 tonnes annually, with L. barbarum being the most widely cultivated variety. The majority of these plantations are located in the Ningxia Hui Autonomous Region and the Xinjiang Uyghur Autonomous Region.
Common Forms and Preparations
The berry is eaten raw, consumed in juice form, or added to tea or wine. The fruit is also processed to make tinctures, powders, and tablets. The main berry products for export are manufactured beverages, juice concentrate, dried berries, snacks, and freeze-dried juice powder and berries. The fruit (fructus Lycii) and bark (cortex Lycii radicis) are the principal herbal raw materials, although therapeutic compounds are also contained in the seeds and leaves.
2. Traditional and Historical Use
Ancient Textual Records
The historical use of L. barbarum dates back over 4,000 years, with its earliest mention in the ancient text "Shen Nong Ben Cao Jing" (The Classic of Herbal Medicine), written between 200 and 250 AD. The Shen Nong Ben Cao Jing classified it as a "superior-grade" herb, attributing to it the functions of "nourishing liver and kidney, replenishing qi, strengthening essence, and promoting longevity."
Use in Traditional Chinese Medicine
Lycium, particularly L. barbarum, has long been used in traditional Chinese medicine. Chinese boxthorn is a major Chinese tonic herb with a history of almost 2,000 years of medicinal use. The fruit and root bark, and to a lesser extent the leaf, of both Lycium barbarum and L. chinense are widely used in traditional medicine in China, Korea, Japan, and Vietnam. Both the berries and the root are considered to promote good health and longevity, tonifying the liver and kidneys, moistening the lungs, nourishing the blood, and enriching yin.
Both the berries and the root are used; traditionally the plant is believed to promote long life. The fruit is one of the most popular tonics used in Chinese herbal medicine. A decoction is used to clear the vision, strengthen the kidneys, restore semen, and nourish the liver. It is also used in the treatment of diabetes mellitus, vertigo, nocturnal emissions, and aching back and legs.
The berries are used for blurry vision and diminished visual acuity, infertility, abdominal pain, dry cough, fatigue, and headache; to increase longevity; and against prematurely gray hair.
Lycium chinense is used in traditional Chinese medicine for the treatment of night sweats, pneumonia, cough, hematemesis, inflammation, and diabetes mellitus.
Use of the Root Bark
Lycii Radicis Cortex (LRC), the dried root bark of Lycium chinense Mill., has traditionally been used as a medicinal herb in East Asia to treat fever and hyperhidrosis. In traditional Chinese medicine theory, it has the effects of clearing away heat-evil and expelling superficial evils. Modern pharmacological studies have found that Lycii cortex contains alkaloids, organic acids, anthraquinones, and peptides, and it plays a pharmacological role in anti-hypertension, anti-hyperglycemia, relieving fever, and analgesia.
Use in Classical European and Greco-Roman Traditions
In his Naturalis Historia, Pliny the Elder describes boxthorn as a medicinal plant, as does Pedanius Dioscorides in his pharmacological writings. Lycium has been known to European herbalists since ancient times, and species were traded from the Far East to Europe by the Romans, for example via Ariaca and the port of Barbarikon near today's Karachi, as mentioned in the Periplus of the Erythraean Sea.
Traditional Food Preparations
As a food, dried wolfberries are traditionally cooked before consumption. Dried wolfberries are often added to rice congee and almond jelly, as well as used in Chinese tonic soups in combination with chicken or pork, vegetables, and other herbs such as wild yam, Astragalus membranaceus, Codonopsis pilosula, and licorice root. The berries are also boiled as a herbal tea, often along with chrysanthemum flowers and/or red jujubes, or with tea. Various wines containing wolfberries are also produced, including some that are a blend of grape wine and wolfberries.
Use Across East Asia
The fruit has also been an ingredient in East Asian traditional medicine, namely traditional Chinese, Japanese, and Korean medicine. In some regions, such as Japan and South Korea, the fruit of L. chinense Mill. is also used, although these two species have obvious differences in their metabolomic profiles.
3. Key Constituents and Active Compounds
Lycium barbarum contains abundant Lycium barbarum polysaccharides (LBPs), betaine, phenolics, carotenoids (zeaxanthin and β-carotene), cerebroside, 2-O-β-d-glucopyranosyl-l-ascorbic acid (AA-2βG), β-sitosterol, flavonoids, and vitamins (in particular, riboflavin, thiamine, and ascorbic acid). The leaves, fruits, and the root bark of Lycium barbarum contain abundant polysaccharides, carotenoids, flavonoids, alkaloids, amides, peptides, anthraquinones, coumarins, lignanoids, terpenoids, sterols, steroids, organic acids, anthocyanins, essential oils, and glycolipids.
Lycium Barbarum Polysaccharides (LBPs)
LBPs are the primary active components of Lycium barbarum, comprising 5–8% of the dried fruits. Currently, over 30 polysaccharides have been extracted and characterized from Lycium barbarum. Analysis of the monomeric composition of these polysaccharides revealed that they primarily consist of nine different monosaccharides: mannose, rhamnose, galactose, xylose, arabinose, fucose, glucose, galacturonic acid, and glucuronic acid.
The structural backbones of the polysaccharides are predominantly made up of (1→4)-β-Galp, (1→3)-β-Galp, (1→6)-α-glucans, (1→6)-β-Galp, and (1→4)-α polygalacturonans, featuring various branches and terminal structures. The glycan derived from L. barbarum has a backbone primarily consisting of (1→6)-β-galactosyl residues, with approximately 50% of these residues substituted at C-3 by either galactosyl or arabinosyl groups.
Carotenoids
Carotenoids, particularly zeaxanthin, play a key role in ocular health. A study of 34 batches of L. barbarum found average concentrations of zeaxanthin (845.39 mg/kg), cryptoflavin (722.94 mg/kg), β-carotene (193.53 mg/kg), and neoxanthin (160.35 mg/kg). Scientists have identified carotenoids in Lycium barbarum, finding zeaxanthin, β-carotene, and zeaxanthin dipalmitate. Nine components were found in Lycium barbarum carotenoid extract using HPLC, including all-trans-zeaxanthin and its isomers, all-trans-β-carotene and its isomers, neoxanthin, and β-cryptoxanthin. The maximum content of all-trans-zeaxanthin and its isomers was 1666.3 μg/g.
Betaine and Other Small Molecules
The predominant carotenoid in boxthorn is zeaxanthin, comprising about one-third to one-half of the total carotenoids. Other chemical constituents found in Lycium barbarum fruit include small molecules such as betaine, cerebroside, beta-sitosterol, p-coumaric acid, and various vitamins. Betaine (trimethylglycine) is a naturally occurring osmolyte and methyl donor also present in the fruit. Modern pharmacological studies have revealed that Lycii Fructus is rich in various bioactive metabolites, particularly Lycium barbarum polysaccharides, betaine, carotenoids, and flavonoids, which exhibit antioxidant, anti-apoptotic, and hormone-regulating effects.
Vitamins
The fruit of many members of this genus is a very rich source of vitamins and minerals, especially vitamins A, C, and E, flavonoids, and other bio-active compounds. It is also a fairly good source of essential fatty acids, which is fairly unusual for a fruit.
4. Established Mechanisms of Action
Antioxidant Activity
The polysaccharides extracted from the fruits of Lycium barbarum exert their anti-aging effect through reducing oxidative stress, modulating the immune response, enhancing neuronal responses, and promoting cytoprotection. LBPs have been reported to mediate significant anti-aging effects through antioxidant, immunoregulative, and anti-apoptotic activities and by reducing DNA damage.
Immunomodulation
Modern pharmacological studies attribute the diverse bioactivities of Lycium barbarum to a key class of active compounds known as LBP. Research has demonstrated that LBP possesses a broad spectrum of pharmacological activities, including antioxidant, anti-aging, neuroprotective, anti-tumor, and notably, immunomodulatory effects.
LBP (100–500 μg/mL) was shown to reduce TNF-α and IL-6 secretion and inhibit NF-κB activation. LBP also reduced apoptosis in gastric mucosal cells, lowered Bax protein expression, and mitigated apoptosis by inhibiting c-Jun N-terminal kinase (JNK) activation.
Mechanistically, LBP promotes the expression of tight junction proteins, activates the Nrf2/Heme oxygenase-1 (HO-1) antioxidant pathway, and inhibits the NF-κB signaling pathway to reduce inflammation.
Neuroprotection
Lycium barbarum L., a traditional Chinese herb used both as food and medicine, contains an active component known as lycium barbarum glycopeptide (LbGp). LbGp has been shown to possess anti-inflammatory, antioxidant, and neuroprotective properties. In models of neurodegenerative diseases such as Parkinson's and Alzheimer's, in vascular-neural injury models like cerebral ischemia, and in ocular disease models including vascular-related glaucoma and retinal ischemia-reperfusion injury, LbGp has been investigated as a neuroprotective agent.
Retinal Protection (Preclinical)
Regarding retinal protection, LBP exhibits significant inhibitory effects on retinal cell apoptosis through various mechanisms. A previous study demonstrated that LBP can effectively prevent ROS generation in the retina of mice exposed to light, potentially through the upregulation of antioxidant genes.
Aqueous and ethanol extracts of L. barbarum fruit were investigated for protective effects against oxidative stress-induced apoptosis in human retinal pigment epithelial cells. Both extracts exerted ROS-scavenging activity and rescued UVB irradiation-induced growth inhibition in retinal pigment epithelial ARPE-19 cells. The ethanol extract exerted superior protective activity on UVB-induced growth arrest in these cells.
Anti-Aging and DNA Damage Reduction
A study used human embryonic lung diploid fibroblasts 2BS national standard strain as an aging model to observe the effect of wolfberry fruit on DNA synthesis. Wolfberry accelerated the DNA synthesis rate of the aging 2BS fusion cells and prolonged their life span, likely through antagonizing growth inhibitory factors. Furthermore, LBPs were effective for reducing cellular DNA damage in peripheral lymphocytes of non-insulin-dependent diabetes mellitus (NIDDM) rats. LBPs decreased DNA damage through suppression of oxidative stress in this model.
5. Scientific Evidence by Area of Use
5.1 Ocular Health and Age-Related Macular Degeneration
The relationship between boxthorn and eye health is among the most researched areas. Lycium barbarum polysaccharides, extracts from the wolfberries, are cited in Chinese medicine as good for "eye health." Preclinical work has been extensive. The therapeutic efficacy of Lycium barbarum polysaccharides in preserving retinal ganglion cells and their functions was demonstrated in a range of experimental models of optic neuropathies, including the acute and chronic ocular hypertension models, the partial optic nerve transection model, and the ischemic-reperfusion injuries model. Based on these findings, Lycium barbarum polysaccharides appear to be a good candidate to be developed as a neuroprotective agent for treating multifactorial diseases.
Lycium barbarum is a traditional Chinese medicinal herb largely consumed to improve eye health. Fruit extract from Lycium barbarum exhibits anti-aging and multitarget mechanisms in protecting retinal ganglion cells (RGC) in various animal models. In a chronic ocular hypertension (COH) rat model, COH-model rats exhibited marked visual dysfunction, retinal thinning, microvascular impairment, and upregulation of pyroptosis markers. LbGp treatment significantly attenuated these abnormalities and suppressed pyroptosis activation, showing efficacy comparable to a pyroptosis inhibitor (VX-765). This work is preclinical (animal model) and has not yet been replicated in randomized human trials.
Key health benefits highlighted in recent clinical reviews include immune modulation, antioxidative effects, mental health support, ocular health preservation, and metabolic and cardiovascular regulation, with a role in addressing age-related macular degeneration also highlighted. However, large-scale definitive human RCTs for AMD remain limited.
5.2 Immune Function
In recent years, global research on Lycium barbarum has increased exponentially, particularly in the field of immunomodulation, which has emerged as a focal research area. A recent (2025) narrative review summarized recent advances in LBP's immunomodulatory research, with emphasis on its mechanisms of action, and revealed its potential value and application prospects in immune regulation.
Recent human studies highlight the therapeutic potential of L. barbarum across a range of health conditions, including its role in immune support, antioxidant enhancement, mental health, and the management of ocular, metabolic, and cardiovascular disorders, as well as certain cancers and non-alcoholic fatty liver disease (NAFLD). Most of the immunomodulatory evidence, however, derives from in vitro and animal studies, with only a limited number of well-designed human RCTs.
5.3 Metabolic Health: Blood Glucose and Lipids
Several clinical studies have examined the effects of L. barbarum preparations on metabolic parameters. In one study, participants were given capsules containing LBPs (150 mg) and microcrystalline cellulose (150 mg) twice daily for three months. The study demonstrated a significant reduction in serum glucose levels and an improvement in the insulinogenic index. Furthermore, LBP supplementation resulted in higher HDL cholesterol levels, a factor associated with a reduced risk of cardiovascular events.
In a 16-week randomised controlled trial, the effects of L. barbarum on cardiovascular health were investigated by administering 15 g of L. barbarum fruits daily. The results demonstrated improved adherence to a healthy dietary pattern and enhanced blood lipid profiles, including significant improvements in HDL cholesterol.
A study explored the effects of a healthy dietary pattern, with or without wolfberry supplementation (15 g/day for 16 weeks), on blood outgrowth endothelial cells in middle-aged and older adults. While the healthy dietary pattern alone significantly improved endothelial cell colony growth, angiogenic capacity, and migration activity, wolfberry supplementation did not offer additional benefits beyond the dietary pattern. This finding illustrates that not all outcomes benefit from boxthorn supplementation beyond baseline dietary improvements, and evidence remains mixed.
5.4 Cardiovascular Health
L. barbarum, abundant in antioxidants such as polysaccharides, flavonoids, and carotenoids, has been widely studied for its potential cardiovascular benefits, particularly due to its ability to reduce oxidative stress, a key factor in cardiovascular disease. In a study over three months, participants who received LBPs (100 mg/kg body weight daily) or engaged in Qigong exercise experienced reductions in diastolic blood pressure and improvements in lipid profiles. The combination of LBPs and exercise was particularly effective in lowering long-term cardiovascular risk, suggesting that lifestyle factors may enhance the cardiovascular benefits of LBPs. These findings are promising but come from relatively small trials and require replication in larger independent studies.
5.5 Neuroprotection and Anti-Aging
LBPs have been reported to mediate significant anti-aging effects through antioxidant, immunoregulative, anti-apoptotic activities, and reducing DNA damage. The basic scientific evidence for anti-aging effects of LBPs is already available; however, additional studies are needed to understand the mechanisms by which LBPs mediate anti-aging properties. The preponderance of anti-aging and neuroprotection evidence comes from in vitro and animal model work; rigorous multi-centre human RCTs in this domain remain sparse.
5.6 Male Reproductive Health
Lycii Fructus (dried goji berry) has long been used in traditional Chinese medicine for its functions of tonifying the kidney, nourishing essence, soothing the liver, and improving vision, and has been widely applied to enhance male reproductive function. In one randomised clinical trial, after collecting demographic, blood, and semen samples, an intervention group received 400 mg of Lycium barbarum extract orally for two months, while the control group received a placebo. These protective effects have been considered essential for maintaining healthy spermatogenesis and overall male reproductive health, and findings collectively suggest that Lycium barbarum, through its antioxidative and hormonal effects, may serve as a natural option for improving male reproductive health. Evidence in this area is preliminary and comes from small or preclinical trials.
5.7 Anti-Tumor Activity
LBP is a natural functional component that has a variety of biological activities. Investigations into the apoptosis-inducing activities of two LBP fractions on human hepatoma SMMC-7721 cells showed that both fractions consist of protein, uronic acid, and neutral sugars in different proportions. LBP-d was composed of eight kinds of monosaccharides, while LBP-e was composed of six kinds of monosaccharides. Both LBP-d and LBP-e blocked SMMC-7721 cells at the G0/G1 and S phases with inhibition ratios of 26.70 and 45.13%, respectively, and enhanced the concentration of intracellular calcium in the cytoplasm of these cells. These findings are limited to in vitro hepatoma cell models; no human clinical evidence for anti-tumor effects has been established.
6. Body Systems and Health Areas Associated with Boxthorn
- Ocular system: Carotenoids, particularly zeaxanthin, play a key role in ocular health, and LBPs have been extensively studied for retinal ganglion cell neuroprotection in preclinical models.
- Immune system: The bioactive components in Lycium barbarum exhibit the effects of antioxidation, immune regulation, hypoglycemic effects, and vision improvement.
- Metabolic/endocrine system: LBP's sugar chain structures endow it with unique biological activities, including immune regulation, antioxidant properties, hypoglycemic effects, and lipid-lowering capabilities.
- Cardiovascular system: L. barbarum has been widely studied for its potential cardiovascular benefits due to its ability to reduce oxidative stress.
- Nervous system / neuroprotection: Research has demonstrated that LBP possesses neuroprotective activities.
- Liver: The fruit protects the liver from damage caused by exposure to toxins according to traditional claims, with modern studies beginning to examine hepatoprotective mechanisms.
- Kidney: Its dried fruit is used as a traditional Chinese medicine for its beneficial effects on the kidney and liver, as well as for nourishing the liver and kidney and replenishing vital essence to improve eyesight.
- Male reproductive system: Modern pharmacological studies have revealed that Lycii Fructus is rich in bioactive metabolites, particularly polysaccharides, betaine, carotenoids, and flavonoids, which exhibit antioxidant, anti-apoptotic, and hormone-regulating effects relevant to male reproductive health.
7. Dosage Forms and Dosages Reported in Studies
Dosage in studies varies substantially by form of administration (whole fruit, juice, standardized extract, or isolated LBP). The following doses have been reported in cited sources:
- LBP capsules: 150 mg LBP plus 150 mg microcrystalline cellulose, taken twice daily for three months, in a clinical study examining glucose and lipid outcomes.
- Whole dried fruit: 15 g of L. barbarum fruits administered daily in a 16-week randomised controlled trial.
- LBP dose of 100 mg/kg body weight daily, administered over three months, in a cardiovascular study.
- 400 mg of Lycium barbarum extract orally for two months, in a randomised clinical trial on male reproductive health.
- In a mouse model of retinal ischemia-reperfusion injury, LBP was administered orally at 1 mg/kg once a day for one week prior to induction of ischemia.
- Oral administration of LbGP at 1 mg/kg (or PBS for vehicle control) was given once daily in an animal model of retinal ganglion cell degeneration.
No single universally accepted therapeutic dosage for human use has been established in the peer-reviewed literature, and the above figures reflect study-specific protocols, not standardized recommendations.
8. Safety Considerations and Drug Interactions
General Safety Profile
The injection of 2.4 g/kg of L. barbarum fruit extract did not cause adverse reactions; the LD50 by injection was determined to be about 8.3 g/kg in animal studies. Aqueous extract of Lycium barbarum showed a high amount of polyphenols (6.19 ± 0.3 mg EAG/g) and significant antioxidant activity. No significant differences between biochemical and hematological profiles, or even signs of toxicity of the extract, were observed when administered alone in animal studies.
Warfarin Interaction — Case Report Evidence
The most clinically important documented interaction involves warfarin (coumarin anticoagulants). There were two case reports of a possible interaction of Lycium fruit tea with warfarin. One reported an 80-year-old Chinese woman on a chronic stable dose of warfarin who experienced two episodes of an elevated international normalized ratio (INR) after drinking herbal tea containing Lycium barbarum L. This case illustrated the potential herbal-drug interaction between warfarin and L. barbarum.
A case report described a 65-year-old Chinese man taking a prolonged maintenance dose of warfarin who experienced an elevated INR with associated bleeding after drinking Gouqizi (goji berry) wine. This report illustrated that large doses (more than 6–12 g) of Gouqizi can significantly enhance the anticoagulant action of warfarin.
Application of the Naranjo adverse drug reaction probability scale indicated a probable relationship (score of 6) between elevated INR with associated bleeding and concomitant use of L. barbarum and warfarin. Two other published reports described similar interactions between warfarin and a tea containing L. barbarum.
Experimental data from concomitant use with warfarin showed a significant increase in prothrombin time, with the potential for bleeding. Collectively, these observations suggest the propensity for a clinically important interaction between warfarin and Lycium barbarum L.
In vitro inhibition of CYP2C9 and CYP3A4 by fractions isolated from goji berry fruit has been reported, which may partially explain the observed pharmacokinetic interaction with warfarin (itself a CYP2C9 substrate), though the precise mechanism has not been fully elucidated.
Solanaceae Family Caution
Some caution should be exercised with this species, particularly with regard to its edible leaves, since it belongs to a family that often contains toxins. However, use of the leaves is well documented and fairly widespread in some areas.
Atropine Content
Studies have shown variable levels of atropine in wolfberry fruits, but the investigators have questioned its toxic concentration.
Adulteration
There are some varieties and related species, such as L. barbarum var. aurantiocarpum, L. chinense var. potaninii, L. ruthenicum, and L. truncatum, which can be found on the market as low-cost adulterants.
Interaction with Other Narrow-Therapeutic-Index Drugs
Since drug interactions are not known precisely, it is recommended not to use boxthorn with drugs with a narrow therapeutic index.
9. Regulatory and Pharmacopoeial Status
The European Pharmacopoeia includes only the dried fruit of L. barbarum. Lycium chinense is accepted by the pharmacopoeias of Japan, Korea, and Taiwan, but not included in the pharmacopoeias of China, Europe, UK, and Vietnam. In China, the quality criteria of Lycii Fructus and Lycii Radices Cortex have experienced notable developments over time, and they vary by geographic region. The fruits and/or root bark have been adopted by pharmacopoeias of many countries and regions, but descriptions and quality requirements differ.
10. Summary of Evidence Quality
The overall evidence base for boxthorn/goji berry is characterized by:
- A robust body of in vitro and animal model data, particularly for LBPs, supporting antioxidant, immunomodulatory, neuroprotective, and ocular neuroprotective activities.
- A growing but still limited number of human clinical trials, many of which are small, of short duration, or conducted in specific patient populations, limiting generalizability.
- The basic scientific evidence for anti-aging effects of LBPs is already available; however, additional studies are needed to understand the mechanisms by which LBPs mediate anti-aging properties.
- Clinically documented interaction with warfarin, supported by multiple case reports and animal pharmacokinetic data, warranting caution in patients on anticoagulant therapy.
- No established standardized therapeutic doses for any indication in humans, as study dosing protocols vary widely.
References
Go back